• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C-C 趋化因子受体 2 (CCR2) 调节髓样细胞向肝脏的募集,促进肥胖诱导的肝脂肪变性。

C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis.

机构信息

Department of Medicine, Columbia University, New York, New York, USA.

出版信息

Diabetes. 2010 Apr;59(4):916-25. doi: 10.2337/db09-1403. Epub 2010 Jan 26.

DOI:10.2337/db09-1403
PMID:20103702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2844839/
Abstract

OBJECTIVE

Obesity induces a program of systemic inflammation that is implicated in the development of many of its clinical sequelae. Hepatic inflammation is a feature of obesity-induced liver disease, and our previous studies demonstrated reduced hepatic steatosis in obese mice deficient in the C-C chemokine receptor 2 (CCR2) that regulates myeloid cell recruitment. This suggests that a myeloid cell population is recruited to the liver in obesity and contributes to nonalcoholic fatty liver disease.

RESEARCH DESIGN AND METHODS

We used fluorescence-activated cell sorting to measure hepatic leukocyte populations in genetic and diet forms of murine obesity. We characterized in vivo models that increase and decrease an obesity-regulated CCR2-expressing population of hepatic leukocytes. Finally, using an in vitro co-culture system, we measured the ability of these cells to modulate a hepatocyte program of lipid metabolism.

RESULTS

We demonstrate that obesity activates hepatocyte expression of C-C chemokine ligand 2 (CCL2/MCP-1) leading to hepatic recruitment of CCR2(+) myeloid cells that promote hepatosteatosis. The quantity of these cells correlates with body mass and in obese mice represents the second largest immune cell population in the liver. Hepatic expression of CCL2 increases their recruitment and in the presence of dietary fat induces hepatosteatosis. These cells activate hepatic transcription of genes responsible for fatty acid esterification and steatosis.

CONCLUSIONS

Obesity induces hepatic recruitment of a myeloid cell population that promotes hepatocyte lipid storage. These findings demonstrate that recruitment of myeloid cells to metabolic tissues is a common feature of obesity, not limited to adipose tissue.

摘要

目的

肥胖会引发全身性炎症反应,而这与许多肥胖的临床并发症的发生发展有关。肝脏炎症是肥胖导致肝脏疾病的一个特征,我们之前的研究表明,肥胖小鼠中 C-C 趋化因子受体 2(CCR2)缺失会导致肝脏脂肪变性减少,CCR2 调节骨髓细胞的募集。这表明,在肥胖时有一种骨髓细胞群被募集到肝脏,并导致非酒精性脂肪性肝病。

研究设计和方法

我们使用荧光激活细胞分选技术来测量肥胖的遗传和饮食模型中肝脏白细胞群体。我们对体内模型进行了特征描述,这些模型增加和减少了肥胖调节的 CCR2 表达的肝脏白细胞群体。最后,我们使用体外共培养系统,测量了这些细胞调节肝细胞脂质代谢程序的能力。

结果

我们证明肥胖会激活肝细胞表达 C-C 趋化因子配体 2(CCL2/MCP-1),导致 CCR2(+)髓样细胞募集到肝脏,从而促进肝脂肪变性。这些细胞的数量与体重相关,在肥胖小鼠中,它们是肝脏中第二大免疫细胞群体。肝脏中 CCL2 的表达增加了它们的募集,并在饮食脂肪存在的情况下诱导肝脂肪变性。这些细胞激活了负责脂肪酸酯化和脂肪变性的肝脏基因转录。

结论

肥胖会诱导骨髓细胞群募集到肝脏,促进肝细胞脂质储存。这些发现表明,骨髓细胞向代谢组织的募集是肥胖的一个共同特征,不仅限于脂肪组织。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd9/2844839/af0e31c28ce1/zdb0041060840008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd9/2844839/6224b32048ca/zdb0041060840001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd9/2844839/75fbe19c4cb4/zdb0041060840002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd9/2844839/bffc90ae961f/zdb0041060840003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd9/2844839/f3e0551885e0/zdb0041060840004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd9/2844839/f70dd5c8f5b8/zdb0041060840005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd9/2844839/ac3d0f4ad8e7/zdb0041060840006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd9/2844839/8aeea1a88546/zdb0041060840007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd9/2844839/af0e31c28ce1/zdb0041060840008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd9/2844839/6224b32048ca/zdb0041060840001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd9/2844839/75fbe19c4cb4/zdb0041060840002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd9/2844839/bffc90ae961f/zdb0041060840003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd9/2844839/f3e0551885e0/zdb0041060840004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd9/2844839/f70dd5c8f5b8/zdb0041060840005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd9/2844839/ac3d0f4ad8e7/zdb0041060840006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd9/2844839/8aeea1a88546/zdb0041060840007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fd9/2844839/af0e31c28ce1/zdb0041060840008.jpg

相似文献

1
C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis.C-C 趋化因子受体 2 (CCR2) 调节髓样细胞向肝脏的募集,促进肥胖诱导的肝脂肪变性。
Diabetes. 2010 Apr;59(4):916-25. doi: 10.2337/db09-1403. Epub 2010 Jan 26.
2
CC chemokine receptor 2 promotes recruitment of myeloid cells associated with insulin resistance in nonalcoholic fatty liver disease.CC 趋化因子受体 2 促进与非酒精性脂肪性肝病胰岛素抵抗相关的髓系细胞募集。
Am J Physiol Gastrointest Liver Physiol. 2018 Apr 1;314(4):G483-G493. doi: 10.1152/ajpgi.00213.2017. Epub 2018 Feb 8.
3
CCR2 modulates inflammatory and metabolic effects of high-fat feeding.CCR2调节高脂喂养的炎症和代谢效应。
J Clin Invest. 2006 Jan;116(1):115-24. doi: 10.1172/JCI24335. Epub 2005 Dec 8.
4
Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2.肝脏中巨噬细胞的募集通过 CCR2 促进非酒精性脂肪性肝炎。
Am J Physiol Gastrointest Liver Physiol. 2012 Jun 1;302(11):G1310-21. doi: 10.1152/ajpgi.00365.2011. Epub 2012 Mar 22.
5
Inhibition of the chemokine (C-C motif) ligand 2/chemokine (C-C motif) receptor 2 pathway attenuates hyperglycaemia and inflammation in a mouse model of hepatic steatosis and lipoatrophy.趋化因子(C-C基序)配体2/趋化因子(C-C基序)受体2信号通路的抑制作用可减轻肝脂肪变性和脂肪萎缩小鼠模型中的高血糖和炎症反应。
Diabetologia. 2009 May;52(5):972-81. doi: 10.1007/s00125-009-1309-8. Epub 2009 Mar 10.
6
CCL2-CCR2 signaling promotes hepatic ischemia/reperfusion injury.CCL2-CCR2信号传导促进肝脏缺血/再灌注损伤。
J Surg Res. 2016 May 15;202(2):352-62. doi: 10.1016/j.jss.2016.02.029. Epub 2016 Mar 3.
7
Diet induction of monocyte chemoattractant protein-1 and its impact on obesity.饮食诱导单核细胞趋化蛋白-1及其对肥胖的影响。
Obes Res. 2005 Aug;13(8):1311-20. doi: 10.1038/oby.2005.159.
8
Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.化学趋化因子 CCL2(单核细胞趋化蛋白 1)的药理学抑制可减少慢性肝损伤中的肝巨噬细胞浸润和脂肪性肝炎。
Gut. 2012 Mar;61(3):416-26. doi: 10.1136/gutjnl-2011-300304. Epub 2011 Aug 3.
9
Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.膳食辣椒素可降低高脂肪饮食诱导肥胖小鼠的肥胖诱导性胰岛素抵抗和肝脂肪变性。
Obesity (Silver Spring). 2010 Apr;18(4):780-7. doi: 10.1038/oby.2009.301. Epub 2009 Oct 1.
10
Inhibition of CCR2 ameliorates insulin resistance and hepatic steatosis in db/db mice.抑制CCR2可改善db/db小鼠的胰岛素抵抗和肝脂肪变性。
Arterioscler Thromb Vasc Biol. 2008 Dec;28(12):2195-201. doi: 10.1161/ATVBAHA.108.168633. Epub 2008 Sep 25.

引用本文的文献

1
The Intriguing Roles of Cytokines in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review.细胞因子在代谢功能障碍相关脂肪性肝病中的有趣作用:一篇叙述性综述
Curr Obes Rep. 2025 Aug 12;14(1):65. doi: 10.1007/s13679-025-00657-5.
2
Regulation of hepatic Sirt1 expression and lipid metabolism through TNF receptor signaling.通过肿瘤坏死因子受体信号传导调节肝脏Sirt1表达和脂质代谢。
Front Immunol. 2025 Jul 22;16:1627433. doi: 10.3389/fimmu.2025.1627433. eCollection 2025.
3
Knowledge landscape of macrophage research in liver fibrosis: a bibliometric review of the literature from WoSCC.

本文引用的文献

1
Immature myeloid cells induced by a high-fat diet contribute to liver inflammation.高脂饮食诱导的未成熟髓样细胞会导致肝脏炎症。
Hepatology. 2009 Nov;50(5):1412-20. doi: 10.1002/hep.23148.
2
Inhibition of the chemokine (C-C motif) ligand 2/chemokine (C-C motif) receptor 2 pathway attenuates hyperglycaemia and inflammation in a mouse model of hepatic steatosis and lipoatrophy.趋化因子(C-C基序)配体2/趋化因子(C-C基序)受体2信号通路的抑制作用可减轻肝脂肪变性和脂肪萎缩小鼠模型中的高血糖和炎症反应。
Diabetologia. 2009 May;52(5):972-81. doi: 10.1007/s00125-009-1309-8. Epub 2009 Mar 10.
3
The role of the lipogenic pathway in the development of hepatic steatosis.
肝纤维化中巨噬细胞研究的知识图谱:基于科学引文索引扩展版(WoSCC)文献的文献计量学综述
Front Pharmacol. 2025 May 8;16:1571879. doi: 10.3389/fphar.2025.1571879. eCollection 2025.
4
Intestinal IL-25 prevents high-fat diet-induced obesity by modulating the cholesterol transporter NPC1L1 expression in the intestinal epithelial cells.肠道白细胞介素-25通过调节肠道上皮细胞中胆固醇转运蛋白NPC1L1的表达来预防高脂饮食诱导的肥胖。
Sci Rep. 2025 Mar 26;15(1):10445. doi: 10.1038/s41598-025-95516-7.
5
Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver disease.胆汁酸激活受体:整合非酒精性脂肪性肝病中的免疫与代谢调节
Liver Res. 2021 Sep 2;5(3):119-141. doi: 10.1016/j.livres.2021.08.003. eCollection 2021 Sep.
6
Rocaglamide-A mitigates LPS-induced hepatic inflammation by modulating JNK/AP-1 signaling cascade and ROS production in hepatocytes.罗卡酰胺 A 通过调节肝细胞中的 JNK/AP-1 信号级联反应和活性氧生成来减轻脂多糖诱导的肝脏炎症。
Toxicol Res. 2024 Sep 27;41(1):47-59. doi: 10.1007/s43188-024-00263-y. eCollection 2025 Jan.
7
Pinpointing the integration of artificial intelligence in liver cancer immune microenvironment.精准定位人工智能在肝癌免疫微环境中的整合情况。
Front Immunol. 2024 Dec 20;15:1520398. doi: 10.3389/fimmu.2024.1520398. eCollection 2024.
8
Brd4 modulates metabolic endotoxemia-induced inflammation by regulating colonic macrophage infiltration in high-fat diet-fed mice.Brd4通过调节高脂饮食喂养小鼠的结肠巨噬细胞浸润来调节代谢性内毒素血症诱导的炎症。
Commun Biol. 2024 Dec 28;7(1):1708. doi: 10.1038/s42003-024-07437-2.
9
Understanding Macrophage Complexity in Metabolic Dysfunction-Associated Steatotic Liver Disease: Transitioning from the M1/M2 Paradigm to Spatial Dynamics.了解代谢功能障碍相关脂肪性肝病中的巨噬细胞复杂性:从M1/M2范式向空间动态转变
Livers. 2024 Sep;4(3):455-478. doi: 10.3390/livers4030033. Epub 2024 Sep 13.
10
The immunology of sickness metabolism.疾病代谢的免疫学。
Cell Mol Immunol. 2024 Sep;21(9):1051-1065. doi: 10.1038/s41423-024-01192-4. Epub 2024 Aug 6.
脂肪生成途径在肝脂肪变性发展中的作用。
Diabetes Metab. 2008 Dec;34(6 Pt 2):643-8. doi: 10.1016/S1262-3636(08)74599-3.
4
Glyceroneogenesis is the dominant pathway for triglyceride glycerol synthesis in vivo in the rat.甘油异生作用是大鼠体内甘油三酯甘油合成的主要途径。
J Biol Chem. 2008 Oct 10;283(41):27565-27574. doi: 10.1074/jbc.M804393200. Epub 2008 Jul 28.
5
Regulation of hepatic lipogenesis by the transcription factor XBP1.转录因子XBP1对肝脏脂肪生成的调控
Science. 2008 Jun 13;320(5882):1492-6. doi: 10.1126/science.1158042.
6
Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance.过氧化物酶体增殖物激活受体δ(PPARδ)介导的库普弗细胞替代性M2激活可改善肥胖诱导的胰岛素抵抗。
Cell Metab. 2008 Jun;7(6):496-507. doi: 10.1016/j.cmet.2008.04.003.
7
Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity.脂肪细胞衍生的Th2细胞因子和髓系过氧化物酶体增殖物激活受体δ调节巨噬细胞极化和胰岛素敏感性。
Cell Metab. 2008 Jun;7(6):485-95. doi: 10.1016/j.cmet.2008.04.002.
8
Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents.脂质诱导的啮齿动物肝脏内质网应激对载脂蛋白B100分泌的抑制作用。
J Clin Invest. 2008 Jan;118(1):316-32. doi: 10.1172/JCI32752.
9
Obesity-induced inflammation: a metabolic dialogue in the language of inflammation.肥胖诱导的炎症:一场用炎症语言进行的代谢对话。
J Intern Med. 2007 Oct;262(4):408-14. doi: 10.1111/j.1365-2796.2007.01852.x.
10
Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects.参与脂肪酸分配与结合、脂肪分解、单核细胞/巨噬细胞募集及炎症反应的基因,在胰岛素抵抗受试者的人类脂肪肝中过度表达。
Diabetes. 2007 Nov;56(11):2759-65. doi: 10.2337/db07-0156. Epub 2007 Aug 17.